- Home
- ZVRA vs FINS Comparison
ZVRA vs FINS Comparison
Compare ZVRA & FINS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZVRA
- FINS
- Stock Information
- Founded
- ZVRA 2006
- FINS 2019
- Country
- ZVRA United States
- FINS United States
- Employees
- ZVRA N/A
- FINS N/A
- Industry
- ZVRA Biotechnology: Pharmaceutical Preparations
- FINS Finance/Investors Services
- Sector
- ZVRA Health Care
- FINS Finance
- Exchange
- ZVRA Nasdaq
- FINS Nasdaq
- Market Cap
- ZVRA 467.6M
- FINS 447.8M
- IPO Year
- ZVRA 2015
- FINS N/A
- Fundamental
- Price
- ZVRA $10.54
- FINS N/A
- Analyst Decision
- ZVRA Strong Buy
- FINS
- Analyst Count
- ZVRA 8
- FINS 0
- Target Price
- ZVRA $22.57
- FINS N/A
- AVG Volume (30 Days)
- ZVRA 2.6M
- FINS 78.0K
- Earning Date
- ZVRA 11-11-2025
- FINS 01-01-0001
- Dividend Yield
- ZVRA N/A
- FINS 9.97%
- EPS Growth
- ZVRA N/A
- FINS N/A
- EPS
- ZVRA N/A
- FINS N/A
- Revenue
- ZVRA $62,020,000.00
- FINS N/A
- Revenue This Year
- ZVRA $336.43
- FINS N/A
- Revenue Next Year
- ZVRA $54.26
- FINS N/A
- P/E Ratio
- ZVRA N/A
- FINS N/A
- Revenue Growth
- ZVRA 161.81
- FINS N/A
- 52 Week Low
- ZVRA $6.19
- FINS $11.61
- 52 Week High
- ZVRA $13.16
- FINS $12.57
- Technical
- Relative Strength Index (RSI)
- ZVRA 58.13
- FINS 56.81
- Support Level
- ZVRA $9.08
- FINS $13.00
- Resistance Level
- ZVRA $11.08
- FINS $13.29
- Average True Range (ATR)
- ZVRA 0.62
- FINS 0.12
- MACD
- ZVRA 0.24
- FINS 0.01
- Stochastic Oscillator
- ZVRA 72.23
- FINS 80.31
About ZVRA Zevra Therapeutics Inc.
Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.
About FINS Angel Oak Financial Strategies Income Term Trust of Beneficial Interest
Angel Oak Financial Strats Income Term is a non-diversified, closed-end management investment company. The fund's objective is to seek current income with a secondary objective of total return. In pursuing its investment objective, the fund invests mainly in debt issued by financial institutions, including subordinated debt, unrated debt, senior debt, and high-yield securities.